Bushido Capital US Equity ETF (SMRI)

Assets	$500.28M
Expense Ratio	0.71%
PE Ratio	15.94
Shares Out	13.78M
Dividend (ttm)	$0.65
Dividend Yield	1.78%
Ex-Dividend Date	Sep 29, 2025
Payout Frequency	Quarterly
Payout Ratio	28.33%

Volume	2,177
Open	36.78
Previous Close	36.53
Day's Range	36.72 - 36.78
52-Week Low	26.95
52-Week High	37.04
Beta	0.91
Holdings	47
Inception Date	Sep 14, 2023

About SMRI

Fund Home Page

The Bushido Capital US Equity ETF (SMRI) is an exchange-traded fund that mostly invests in total market equity. The fund actively manages an equally weighted portfolio of 30 to 50 US stocks believed to be undervalued but financially attractive. The funds stock selection involves a fundamental value approach. SMRI was launched on Sep 14, 2023 and is issued by Bushido.

• Asset Class: Equity
• Category: Mid-Cap Value
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: SMRI
• ETF Provider: Bushido

Top 10 Holdings

25.76% of assets

Name	Symbol	Weight
Regeneron Pharmaceuticals, Inc.	REGN	2.78%
Cardinal Health, Inc.	CAH	2.77%
Expedia Group, Inc.	EXPE	2.70%
Merck & Co., Inc.	MRK	2.67%
United Parcel Service, Inc.	UPS	2.54%
lululemon athletica inc.	LULU	2.54%
Newmont Corporation	NEM	2.48%
Incyte Corporation	INCY	2.43%
Accenture plc	ACN	2.43%
Cisco Systems, Inc.	CSCO	2.42%

Dividends

Ex-Dividend	Amount	Pay Date
Sep 29, 2025	$0.14942	Sep 30, 2025
Jun 27, 2025	$0.05509	Jun 30, 2025
Mar 28, 2025	$0.1386	Mar 31, 2025
Dec 30, 2024	$0.30629	Dec 31, 2024
Dec 20, 2023	$0.11857	Dec 22, 2023

Performance

SMRI had a total return of 19.72% in the past year, including dividends. Since the fund's inception, the average annual return has been 19.02%.